In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Modification Regulation as regards botanical species containing hydroxyanthracene derivatives

Modification Regulation as regards botanical species containing hydroxyanthracene derivatives

by In2Pharma | Mar 29, 2021 | News

Europe Commission Regulation (EU) 2021/468 of 18 March 2021 amends Annex III to Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and of certain other substances to food as regards botanical species containing hydroxyanthracene...

Recent Posts

  • Update NDS-web platform
  • Maximum limits nutrients food supplements
  • Maximum hospitality limits increased
  • CGR publishes new maximum hourly rates for 2027
  • GAIA self-assessment on hospitality rules now also applies to medical device companies

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België